E-ISSN 0976-2779 | ISSN 0975-8453
 

Review Article 


Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE)

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan.

Abstract
One of hepatocellular carcinoma (HCC) therapeutic modality is transarterial chemoembolization (TACE). The albumin-bilirubin (ALBI) grade is amongst the newest of prognostic scores published to predict survival. The aim of this study was to analzye the ALBI grade as a three-month survival predictor in HCC patients after initial TACE. This was a retrospective analytic observational study identifying patients that underwent initial TACE from January 2013 to December 2017 in Dr. Soetomo General Hospital, Surabaya. Data were collected before treatment and analyzed to evaluate ALBI grade as a survival predictor. Out of 134 HCC patients, the subjects consisted of 100 (74.6%) male subjects and 34 (25.4%) female subjects. There were 25 (18.7%), 98 (73.1%), dan 11 (8.2%) subjects who were classified into to ALBI 1, ALBI 2, and ALBI 3, respectively, with a median ALBI score of -2.295. The ALBI grade was significantly associated with the three-month survival variable (p = 0.01; CI 95%). Using the ROC curve, we have determined a new cut-off point. The group of ALBI score ≤ -2.27 had an odds ratio of 2.549 (CI 95% 1.232-5.273) for three-month survival. The ALBI grade was associated with three-month survival after initial TACE in patients with HCC.

Key words: HCC, TACE, ALBI grade, survival


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Ummi Maimunah
Articles by Andri Pramana Restu
Articles by Iswan Abbas Nusi
Articles by Herrry Purbayu
Articles by Titong Sugihartono
Articles by Ulfa Kholili
Articles by Budi Widodo
Articles by Muhammad Miftahussurur
Articles by Husin Thamrin
Articles by Amie Vidyani
Articles by Poernomo Boedi Setiawan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). SRP. 2020; 11(5): 205-208. doi:10.31838/srp.2020.5.31


Web Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). http://www.sysrevpharm.org//?mno=108415 [Access: May 31, 2020]. doi:10.31838/srp.2020.5.31


AMA (American Medical Association) Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). SRP. 2020; 11(5): 205-208. doi:10.31838/srp.2020.5.31



Vancouver/ICMJE Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). SRP. (2020), [cited May 31, 2020]; 11(5): 205-208. doi:10.31838/srp.2020.5.31



Harvard Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan (2020) Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). SRP, 11 (5), 205-208. doi:10.31838/srp.2020.5.31



Turabian Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. 2020. Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). Systematic Reviews in Pharmacy, 11 (5), 205-208. doi:10.31838/srp.2020.5.31



Chicago Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. "Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE)." Systematic Reviews in Pharmacy 11 (2020), 205-208. doi:10.31838/srp.2020.5.31



MLA (The Modern Language Association) Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan. "Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE)." Systematic Reviews in Pharmacy 11.5 (2020), 205-208. Print. doi:10.31838/srp.2020.5.31



APA (American Psychological Association) Style

Ummi Maimunah, Andri Pramana Restu, Iswan Abbas Nusi, Herrry Purbayu, Titong Sugihartono, Ulfa Kholili, Budi Widodo, Muhammad Miftahussurur, Husin Thamrin, Amie Vidyani, Poernomo Boedi Setiawan (2020) Albumin-Bilirubin Grade as a Three-Month Survival Predictor in Hepatocellular Carcinoma Patients after Initial Transarterial Chemoembolization (ALBI Grade Predicting Survival in HCC Treated With TACE). Systematic Reviews in Pharmacy, 11 (5), 205-208. doi:10.31838/srp.2020.5.31